1.
Kaloyannidis P, Al Shaibani E, Moinnudin A, Al Anezi K, Al Hashmi H. Repeated courses of escalating doses of Nivolumab in refractory Hodgkin lymphoma with recurrent relapses post allografting: A safe and effective treatment approach. Hematol Rep [Internet]. 2021Mar.5 [cited 2021Jul.26];13(1). Available from: https://www.pagepress.org/journals/index.php/hr/article/view/8780